FDA approves cheaper Botox rival to treat frown lines

An injection to treat forehead wrinkles is set to rival Allergan's Botox after U.S. regulators approved Evolus Inc's cheaper treatment on Friday, sending its shares up about 5 percent after the bell.

Source: Reuters: Health - February 1, 2019 Category: Consumer Health News Tags: healthNews Source Type: news